Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Wurz, R.P., Pettus, L.H., Henkle, B., Sherman, L., Plant, M., Miner, K., McBride, H.J., Wong, L.M., Saris, C.J., Lee, M.R., Chmait, S., Mohr, C., Hsieh, F., Tasker, A.S.(2010) Bioorg Med Chem Lett 20: 1680-1684
- PubMed: 20138761 
- DOI: 10.1016/j.bmcl.2010.01.059
- Primary Citation of Related Structures:  
3ITZ - PubMed Abstract: 
A novel class of pyrazolopyridazine p38alpha mitogen-activated protein kinase (MAPK) inhibitors is disclosed. A structure activity relationship (SAR) investigation was conducted driven by the ability of these compounds to inhibit the p38alpha enzyme, the secretion of TNFalpha in a LPS-challenged THP1 cell line and TNFalpha-induced production of IL-8 in the presence of 50% human whole blood (hWB) ...